UC San Diego FIRST Program
加州大学圣地亚哥分校 FIRST 项目
基本信息
- 批准号:10701801
- 负责人:
- 金额:$ 22.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-09 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdvanced DevelopmentAreaAwardBudgetsCaliforniaCollaborationsCommunitiesCompetenceDevelopmentDevelopment PlansEducational process of instructingElementsEnvironmentEquityEthnic OriginEthnic PopulationFacultyFosteringFundingGoalsGrantInstitutionInterventionKnowledgeLeadershipManuscriptsMentorsMentorshipMethodologyOrganizational CultureParticipantPopulationPositioning AttributePreparationProcessProductivityProgram DevelopmentRaceRecommendationResearchResearch PersonnelResearch TrainingSchoolsScientistServicesStructureSystemTeacher Professional DevelopmentTraining ProgramsUnited States National Institutes of HealthUniversitiesWomanWritingcareercareer developmentcareer networkingcohortcommunity buildingdesignevidence basefaculty supporthealth equityimprovedinnovationpatient engagementpeerpeer coachingprogramsrecruitresearch and developmentresearch facultysenior facultyskillssuccesswomen facultywomen of color
项目摘要
Abstract
A diverse biomedical workforce is critical for enhancing scientific innovation, health equity, and inclusive
excellence. However, the number of historically underrepresented racial/ethnic (UR) scientists and women,
especially UR women remain disproportionately low in the biomedical workforce, particularly as faculty at
research institutions. UR and women biomedical researchers are also less likely to be awarded NIH funding and
are underrepresented in leadership positions. Key barriers to faculty retention and success include a lack of
clarity regarding promotion criteria, effective mentorship and formal structured faculty development programs. In
addition, the gap in representation is caused in large part by institutional cultures that lack critical elements of
inclusion and equity. Thus, multiple evidence-based strategies are needed to enhance faculty diversity, success
and inclusion. Cluster hiring at academic institutions is an effective strategy for enhancing faculty diversity.
Formal structured faculty mentorship, research and career development programs improve faculty competencies
and success and can impact organizational culture. The goal of the University of California San Diego (UCSD)
Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Faculty Development Core is to use
evidence-based strategies to enhance FIRST participants’ academic advancement, research success, and
inclusive institutional excellence. The objective of the Faculty Development Core is to develop institutional
strategies to establish effective mentorship, enhance research and career development and promote
interventions that will reduce isolation and increase community building for all UCSD FIRST participants. We
hypothesize that UCSD FIRST cohort participants engaging in the Faculty Development Core program
components will obtain direction in academic promotion, strong mentorship in research and career development,
access to networks of colleagues, integration into their units and inclusion in robust communities of diverse
scholars comprised of peers, near-peers and senior faculty across UCSD. We propose three specific aims. Aim
1. Strategy and Methodology. To improve UCSD FIRST faculty training for promotion, tenure and advancement
and enhance integration into the department/division and institution. Aim 2. Professional Development and
Progression. To improve and support faculty research and career development using evidence-based strategies.
Aim 3. Culture and Environment. To reduce isolation, promote community building, support new faculty timely
academic advancement and to enhance institutional inclusive excellence. Together, these aims will promote
UCSD culture change towards inclusive excellence by using evidence-based strategies to enhance UR faculty
academic advancement, research and career development, integration and implementation of system-wide
structured faculty development programs to enhance inclusivity.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIVIAN REZNIK其他文献
VIVIAN REZNIK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIVIAN REZNIK', 18)}}的其他基金
UC San Diego RAPID Faculty Development Program in Infectious Diseases
加州大学圣地亚哥分校传染病快速教师发展计划
- 批准号:
10677670 - 财政年份:2020
- 资助金额:
$ 22.12万 - 项目类别:
San Diego Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Program
圣地亚哥领导推动代表性不足的神经科学家变革(LAUNCH)计划
- 批准号:
10455485 - 财政年份:2020
- 资助金额:
$ 22.12万 - 项目类别:
UC San Diego RAPID Faculty Development Program in Infectious Diseases
加州大学圣地亚哥分校传染病快速教师发展计划
- 批准号:
10065877 - 财政年份:2020
- 资助金额:
$ 22.12万 - 项目类别:
San Diego Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Program
圣地亚哥领导推动代表性不足的神经科学家变革(LAUNCH)计划
- 批准号:
10206279 - 财政年份:2020
- 资助金额:
$ 22.12万 - 项目类别:
San Diego Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Program
圣地亚哥领导推动代表性不足的神经科学家变革(LAUNCH)计划
- 批准号:
10674057 - 财政年份:2020
- 资助金额:
$ 22.12万 - 项目类别:
San Diego Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Program
圣地亚哥领导“代表性不足的神经科学家促进变革”(LAUNCH)计划
- 批准号:
10024515 - 财政年份:2020
- 资助金额:
$ 22.12万 - 项目类别:
UC San Diego RAPID Faculty Development Program in Infectious Diseases
加州大学圣地亚哥分校传染病快速教师发展计划
- 批准号:
10456645 - 财政年份:2020
- 资助金额:
$ 22.12万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 22.12万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 22.12万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 22.12万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 22.12万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 22.12万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 22.12万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 22.12万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 22.12万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 22.12万 - 项目类别:














{{item.name}}会员




